Post by
Hiddensecrets on Jul 09, 2021 1:35pm
Buyer of PP is Pfizer (for blowfish)
I believe that the buyer of the entire pp is Pfizer. It is no secret that they want to get their hands on blowfish technology. With pp and warrants Pfizer will own and control 60% of Medv. It is in essence a buyout. The other 40% is rewarded to Medv shareholders as they will aggressively push this technology to world markets resulting in a soaring price. This is the wild card and explains $60 million forecast in 2021 and why David said, Now is not the time you want to be short Mpo
Comment by
Frosted on Jul 09, 2021 5:06pm
I hear Pfizer is competeing with Moderna on who gets Bowfish. Anyone know if Cannacord bailed and took their loss from investment on MEDV? And if they were the ones who gradually sold off little by little?
Comment by
Suggardaddy68 on Jul 09, 2021 10:42pm
man you are so fkn full of sh*t , the deal is dead with MDX & MEDV, nothing further will come from the contract, initial investment is all we got and that's 14% so saying Pfizer buying the medv pp gives them 60% of Marvel is so stupid go away already
Comment by
Frosted on Jul 10, 2021 9:25am
Wow. You can put quite the spin on it HS. Sure hope you're right cause Sarb has left the building and has refused comment altogether
Comment by
fuquebec on Jul 10, 2021 9:52am
This post has been removed in accordance with Community Policy